Acute Myocardial Infarction Up in People With Epilepsy, 2008 to 2017

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 18, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 18, 2024 -- The prevalence of acute myocardial infarction (AMI) in people with epilepsy increased from 2008 to 2017, according to a study published online Aug. 4 in Frontiers in Neurology.

Zhemin Pan, from Tongji University School of Medicine in Shanghai, and colleagues analyzed temporal trends in prevalence, adverse clinical outcomes, and risk factors for AMI in patients with epilepsy. The analysis included data from 8.4 million adult inpatients with an epilepsy diagnosis (2008 through 2017).

The researchers found that comorbid AMI occurred in 2.15 percent of the study population. There was a significant increase in the prevalence of AMI diagnosis in people with epilepsy from 1,911.7 per 100,000 hospitalizations in 2008 to 2,529.5 per 100,000 hospitalizations in 2017. Additionally, people with epilepsy and AMI had significantly higher inpatient mortality versus those without AMI (odds ratio [OR], 4.61). In people with epilepsy, factors significantly associated with AMI included age (75 years and older versus 18 to 44 years old: OR, 3.54), atherosclerosis (OR, 4.44), conduction disorders (OR, 2.21), cardiomyopathy (OR, 2.11), coagulopathy (OR, 1.52), dyslipidemia (OR, 1.26), peptic ulcer disease (OR, 1.23), chronic kidney disease (OR, 1.23), smoking (OR, 1.20), and weight loss (OR, 1.20).

"Mortality rates were high among this population, highlighting the need for comprehensive attention to prophylaxis for risk factors and early diagnosis of AMI in people with epilepsy by physicians," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-09-19 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords